Madhumita Thiagarajan

Madhu is a PhD student at the University of Queensland Centre for Clinical Research (UQCCR) investigating the development of next-generation topical haemostatic materials. Their research focuses on the molecular and cellular mechanisms of haemostasis, with particular emphasis on the individual and synergistic roles of fibrinogen, Factor XIII, fibronectin, and the snake venom derived procoagulant ecarin. The project aims to engineer a dry, bioactive, fully resorbable haemostatic formulation that can be applied directly to bleeding wounds without specialised tools or reconstitution. By optimising clot formation, mechanical stability, wound adherence, and resistance to fibrinolysis, this work seeks to address critical needs in trauma, surgical, and battlefield medicine.